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Background
Inflammatory bowel disease (IBD) is a collective term,
generally referring to ulcerative colitis (UC) and Crohn’s
disease (CD). Distinguishing between the sub-diagnoses of
IBD as well as differential diagnoses such as irritable
bowel syndrome (IBS) poses a challenge to the gastroen-
terologist because of the large overlap in clinical features.
Making a correct diagnosis is important because treatment
alternatives differ greatly between the two entities. Still,
many patients are mis-diagnosed every year, and thus,
there is need for developing improved diagnostic methods.
In this study, we have used flow cytometry to investigate
the expression of 20 chemokine receptors on the CD3+,
CD14+ and CD19+ peripheral blood leukocyte popula-
tions in patients with UC, CD and IBS.
Materials and methods
44 subjects were included in this study (HC=20; UC=4;
CD=11; IBS=9). Leukocytes were isolated from hepari-
nized whole blood by red blood cell lysis using NH4Cl buf-
fer. Cells were Fc-blocked and subsequently stained with
fluorochrome-conjugated antibodies against 20 chemokine
receptors as well as leukocyte subset markers. Expression
was normalized against fluorochrome-matched isotype
controls for all parameters. Samples were analyzed on a
FACSCanto flow cytometer (BD Biosystems). Statistical
analyses were carried out using two-tailed independent
t-test in Statistica 10 software (Statsoft).
Results
9 parameters were found to be differentially expressed
between the IBS and IBD groups. Here, CXCR4 on
CD19+ B cells provided the largest group separation
(p<0.001). Between UC and CD, 12 parameters were able
to distinguish the diagnoses with CXCR5 on CD14+
monocytes accounting for the largest difference in
expression.
Conclusion
Our results show that chemokine receptor expression
profiles on peripheral blood leukocyte subsets differ sig-
nificantly between patients diagnosed with UC, CD and
IBS. Larger studies are needed to evaluate the benefit of
using flow cytometry analyses of chemokine receptors as
a diagnostic complement in IBD/IBS.
Irritable bowel syndrome (IBS) is a symtom-based diag-
nosis characterized by alternating diarrhoea and constipa-
tion, abdominal pain and great discomfort. The causative
mechanisms of IBS are unknown, but it has been sug-
gested that IBS is in fact early-stage inflammatory bowel
disease (IBD). Due to the large overlap in clinical features,
distinguishing IBD from IBS poses a challenge for the
gastroenterologist.
Around one in five Australians experiences the unplea-
sant symptoms of irritable bowel syndrome (IBS) at some
time. These include abdominal pain, mucus in the stools,
and alternating diarrhoea and constipation. Other terms
for irritable bowel syndrome include ‘spastic colon’ and
‘irritable colon’. It seems that people with IBS have sensi-
tive bowels that are easily ‘upset’. More women than men
are prone to IBS, and symptoms tend to first occur in
early adulthood.
The cause is unknown, but environmental factors such
as changes of routine, emotional stress, infection and diet
can trigger an attack. Research has shown that the neuro-
transmitter serotonin may be important in the symptoms1Dept. of Medicine, Translational Immunology Unit, Karolinska Institutet,
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of IBS, by altering the function of nerve cells in the bowel
and causing changes in pain sensation and bowel function.
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